← Browse by Condition
Medical Condition
alk positive large b cell lymphoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1
NCT04231877 Phase 1
Recruiting
Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma
Enrollment
56 pts
Location
United States
Sponsor
University of Washington
NCT05544019 Phase 1
Recruiting
Study of SGR-1505 in Mature B-Cell Neoplasms
Enrollment
98 pts
Location
United States, Franc...
Sponsor
Schrödinger, Inc.